Autoantibody-mediated bladder dysfunction in type 1 diabetes

Scandinavian Journal of Immunology

Volumn 65, Issue 1, 2007, Pages 70-75

  Wan, E C ^a   Gordon, T P ^a   Jackson, M W ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; AUTOANTIBODY; CALCIUM CHANNEL L TYPE; DIHYDROPYRIDINE DERIVATIVE; IMMUNOGLOBULIN G; NICARDIPINE; TETRODOTOXIN; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER COMPLIANCE; BLADDER DYSFUNCTION; BLADDER WALL; CONTROLLED STUDY; DETRUSOR DYSSYNERGIA; DIABETIC NEPHROPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOTOR NERVE BLOCK; MOUSE; NONHUMAN; OVERACTIVE BLADDER; PRIORITY JOURNAL;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; AUTOANTIBODIES; CALCIUM CHANNELS, L-TYPE; DIABETES MELLITUS, TYPE 1; MALE; MICE; MICE, INBRED BALB C; NICARDIPINE; TETRODOTOXIN; URINARY BLADDER; URINARY BLADDER DISEASES;

EID: 33845703426     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01877.x     Document Type: Article

References (30)

1. Bradley WE. Diagnosis of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 1980;92:323-6.
2. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003;26:1553-79.
3. Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol 1995;153:342-4.
4. Sasaki K, Yoshimura N, Chancellor MB. Implications of diabetes mellitus in urology. Urol Clin North Am 2003;30:1-12.
5. Ellenberg M. Development of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 1980;92:321-3.
6. Mastri AR. Neuropathology of diabetic neurogenic bladder. Ann Intern Med 1980;92:316-8.
7. Van Poppel H, Stessens R, Van Damme B, Carton H, Baert L. Diabetic cystopathy: neuropathological examination of urinary bladder biopsies. Eur Urol 1988;15:128-31.
8. Spritz N, Singh H, Marinan B. Metabolism of peripheral nerve myelin in experimental diabetes. J Clin Invest 1975;55:1049-56.
9. Ryle C, Leow CK, Donaghy M. Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus. Muscle Nerve 1997;20:577-84.
10. Duchen LW, Anjorin A, Watkins PJ, Mackay JD. Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med 1980;92:301-3.
11. Sundkvist G, Lind P, Bergstrom B, Lilja B, Rabinowe SL. Autonomic nerve antibodies and autonomic nerve function in type 1 and type 2 diabetic patients. J Intern Med 1991;229:505-10.
12. Zanone MM, Peakman M, Purewal T, Watkins PJ, Vergani D. Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993;36:564-9.
13. Jackson MW, Gordon TP, Waterman SA. Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes. Gastroenterology 2004;126:819-28.
14. Lyford GL, Strege PR, Shepard A et al. alpha(1C) (Ca(V)1.2) L-type calcium channel mediates mechanosensitive calcium regulation. Am J Physiol Cell Physiol 2002;283:C1001-8.
15. Wang F, Jackson MW, Maughan V et al. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder. Arthritis Rheum 2004;50:3637-45.
16. Steinbuch M, Audran R. The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch Biochem Biophys 1969;134:279-84.
17. Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis Rheum 2000;43:1647-54.
18. McLellan A, Cardozo L. Urodynamic techniques. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:266-70.
19. Sillen U. Bladder function in healthy neonates and its development during infancy. J Urol 2001;166:2376-81.
20. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia 2000;43:957-73.
21. Verrotti A, Chiarelli F, Morgese G. Autonomic dysfunction in newly diagnosed insulin-dependent diabetes mellitus children. Pediatr Neurol 1996;14:49-52.
22. Donaghue KC, Fung AT, Fairchild JM, Howard NJ, Silink M. Prospective assessment of autonomic and peripheral nerve function in adolescents with diabetes. Diabet Med 1996;13:65-71.
23. Merio R, Festa A, Bergmann H et al. Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose, and glycemic control. Diabetes Care 1997;20:419-23.
24. Skundric DS, Lisak RP. Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration. Exp Diabesity Res 2003;4:303-12.
25. Kitami K. Vesicourethral dysfunction of diabetic patients. Nippon Hinyokika Gakkai Zasshi 1991;82:1074-83.
26. + concentration in toad stomach smooth muscle cells. J Physiol 2000;524(Pt 1):3-17.
27. Gillespie JI. The autonomous bladder: a view of the origin of bladder overactivity and sensory urge. BJU Int 2004;93:478-83.
28. Levin RM, Kitada S, Hayes L et al. Experimental hyperreflexia: effect of intravesical administration of various agents. Pharmacology 1991;42:54-60.
29. Fry CH, Sui GP, Severs NJ, Wu C. Spontaneous activity and electrical coupling in human detrusor smooth muscle: implications for detrusor overactivity? Urology 2004;63:3-10.
30. Waterman SA, Lang B, Newsom-Davis J. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse. Ann Neurol 1997;42:147-56.